Impact of race and gender on cardiac device implantations

Heart Rhythm

Volumn 4, Issue 11, 2007, Pages 1420-1426

  El Chami, Mikhael F ^a   Hanna, Ibrahim R ^b   Bush, Heather ^c   Langberg, Jonathan J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c REGISTRAT Inc   (United States)

Author keywords

Gender disparity; Implantable defibrillators; Left ventricular dysfunction; Pacemakers; Racial disparity

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEMOGRAPHY; DISEASE CLASSIFICATION; FEMALE; GENDER BIAS; HEALTH INSURANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; QRS COMPLEX; RACE DIFFERENCE; REGISTER; REGRESSION ANALYSIS; SEX RATIO;

AGED; CARDIAC PACING, ARTIFICIAL; CONTINENTAL POPULATION GROUPS; DEFIBRILLATORS, IMPLANTABLE; ETHNIC GROUPS; FEMALE; GENDER IDENTITY; HEALTH STATUS DISPARITIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SEX FACTORS; STROKE VOLUME; SYSTOLE;

EID: 35348891975     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.07.024     Document Type: Article

References (25)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337 (1997) 1576-1583
2. Connolly S.J., Gent M., Roberts R.S., Dorian P., Roy D., Sheldon R.S., Mitchell L.B., Green M.S., Klein G.J., and O'Brien B. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
3. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
4. Kadish A., Dyer A., Daubert J.P., Quigg R., Estes N.A., Anderson K.P., Calkins H., Hoch D., Goldberger J., Shalaby A., Sanders W.E., Schaechter A., and Levine J.H. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
5. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., and Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
6. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L., Ellestad M., Trupp R.J., Underwood J., Pickering F., Truex C., McAtee P., and Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
7. Bleeker G.B., Holman E.R., Steendijk P., Boersma E., van der Wall E.E., Schalij M.J., and Bax J.J. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 48 (2006) 2243-2250
8. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., and Feldman A.M. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
9. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., and Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
10. Gauri A.J., Davis A., Hong T., Burke M.C., and Knight B.P. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med 119 (2006) 167 e17-21
11. Groeneveld P.W., Heidenreich P.A., and Garber A.M. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation 108 (2003) 286-291
12. Groeneveld P.W., Heidenreich P.A., and Garber A.M. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol 45 (2005) 72-78
13. Voigt A., Ezzeddine R., Barrington W., Obiaha-Ngwu O., Ganz L.I., London B., and Saba S. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 44 (2004) 855-858
14. Hanna I.R., Heeke B., Bush H., Brosius L., King-Hageman D., Beshai J.F., and Langberg J.J. The relationship between stature and the prevalence of atrial fibrillation in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 1683-1688
15. Hanna I.R., Heeke B., Bush H., Brosius L., King-Hageman D., Dudley Jr. S.C., Beshai J.F., and Langberg J.J. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 3 (2006) 881-886
16. Blomkalns A.L., Chen A.Y., Hochman J.S., Peterson E.D., Trynosky K., Diercks D.B., Brogan Jr. G.X., Boden W.E., Roe M.T., Ohman E.M., Gibler W.B., and Newby L.K. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 45 (2005) 832-837
17. Chandra N.C., Ziegelstein R.C., Rogers W.J., Tiefenbrunn A.J., Gore J.M., French W.J., and Rubison M. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 158 (1998) 981-988
18. Alexander M., Baker L., Clark C., McDonald K.M., Rowell R., Saynina O., and Hlatky M.A. Management of ventricular arrhythmias in diverse populations in California. Am Heart J 144 (2002) 431-439
19. Kressin N.R., and Petersen L.A. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med 135 (2001) 352-366
20. Peterson E.D., Shaw L.K., DeLong E.R., Pryor D.B., Califf R.M., and Mark D.B. Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter?. N Engl J Med 336 (1997) 480-486
21. Bursi F., Weston S.A., Redfield M.M., Jacobsen S.J., Pakhomov S., Nkomo V.T., Meverden R.A., and Roger V.L. Systolic and diastolic heart failure in the community. JAMA 296 (2006) 2209-2216
22. Sanderson J.E. Heart failure with a normal ejection fraction. Heart 93 (2007) 155-158
23. Davis K., Schoen C., Doty M., and Tenney K. Medicare versus private insurance: rhetoric and reality. Health Aff (Millwood) (2002) W311-W324 Suppl Web Exclusives
24. Ibrahim S.A., Thomas S.B., and Fine M.J. Achieving health equity: an incremental journey. Am J Public Health 93 (2003) 1619-1621
25. Thomas S.B., Fine M.J., and Ibrahim S.A. Health disparities: the importance of culture and health communication. Am J Public Health 94 (2004) 2050